Kim EJ - Search Results

1

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.

Kim WJ, Kim EJ, Kim SK, Kim YJ, Ha YS, Jeong P, Kim MJ, Yun SJ, Lee KM, Moon SK, Lee SC, Cha EJ, Bae SC. Kim WJ, et al. Among authors: kim yj, kim ej, kim sk, kim mj. Mol Cancer. 2010 Jan 8;9:3. doi: 10.1186/1476-4598-9-3. Mol Cancer. 2010. PMID: 20059769 Free PMC article.

2

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.

Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun Wee J, Kim WJ. Kim EJ, et al. Among authors: kim wj, kim j. Urology. 2005 Jan;65(1):70-5. doi: 10.1016/j.urology.2004.08.005. Urology. 2005. PMID: 15667866

3

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, Li QL, Yang JO, Ito Y, Bae SC. Kim WJ, et al. Among authors: kim ej, kim j. Cancer Res. 2005 Oct 15;65(20):9347-54. doi: 10.1158/0008-5472.CAN-05-1647. Cancer Res. 2005. PMID: 16230397

4

Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.

Kim EJ, Kim YJ, Jeong P, Ha YS, Bae SC, Kim WJ. Kim EJ, et al. Among authors: kim yj, kim wj. J Urol. 2008 Sep;180(3):1141-5. doi: 10.1016/j.juro.2008.05.002. Epub 2008 Jul 18. J Urol. 2008. PMID: 18639281

5

Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.

Kim EJ, Lee YS, Kim YJ, Kim MJ, Ha YS, Jeong P, Lee OJ, Kim WJ. Kim EJ, et al. Among authors: kim yj, kim wj, kim mj. Urology. 2010 Jun;75(6):1516.e9-13. doi: 10.1016/j.urology.2009.08.055. Epub 2009 Nov 13. Urology. 2010. PMID: 19913893

6

Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer.

Kim SK, Kim EJ, Leem SH, Ha YS, Kim YJ, Kim WJ. Kim SK, et al. Among authors: kim yj, kim wj, kim ej. BMC Cancer. 2010 Jan 25;10:21. doi: 10.1186/1471-2407-10-21. BMC Cancer. 2010. PMID: 20096140 Free PMC article.

7

Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: a novel approach using peptide nucleic acid-mediated, real-time PCR clamping.

Kim EJ, Yan C, Ha YS, Jeong P, Yi Kim I, Moon SK, Choi YH, Kim WJ. Kim EJ, et al. Among authors: kim wj. Urol Oncol. 2012 Sep;30(5):673-9. doi: 10.1016/j.urolonc.2010.07.008. Epub 2010 Sep 29. Urol Oncol. 2012. PMID: 20884250

8

EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.

Kim YJ, Yoon HY, Kim SK, Kim YW, Kim EJ, Kim IY, Kim WJ. Kim YJ, et al. Among authors: kim iy, kim wj, kim ej, kim sk, kim yw. Clin Cancer Res. 2011 Jul 1;17(13):4523-30. doi: 10.1158/1078-0432.CCR-10-2817. Epub 2011 May 13. Clin Cancer Res. 2011. PMID: 21571867

9

Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression.

Jeong P, Kim EJ, Kim EG, Byun SS, Kim CS, Kim WJ. Jeong P, et al. Among authors: kim cs, kim eg, kim wj, kim ej. Urology. 2004 Nov;64(5):1052-6. doi: 10.1016/j.urology.2004.06.018. Urology. 2004. PMID: 15533517

10

Aqueous extract of Magnolia officinalis mediates proliferative capacity, p21WAF1 expression and TNF-alpha-induced NF-kappaB activity in human urinary bladder cancer 5637 cells; involvement of p38 MAP kinase.

Lee SJ, Kim HM, Cho YH, Park K, Kim EJ, Jung KH, Kim CH, Kim WJ, Moon SK. Lee SJ, et al. Among authors: kim wj, kim hm, kim ej, kim ch. Oncol Rep. 2007 Sep;18(3):729-36. Oncol Rep. 2007. PMID: 17671727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,953 results

Search Page

Filters